ASLN - ASLAN Pharmaceuticals Limited

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Dec 2018)Next qtr. (Mar 2019)Current year (2018)Next year (2019)
No. of analysts3123
Avg. Estimate-0.45-0.38-1.53-1
Low estimate-0.59-0.38-1.63-1.74
High estimate-0.37-0.38-1.42-0.29
Year ago EPSN/AN/AN/A-1.53
Revenue estimateCurrent qtr. (Dec 2018)Next qtr. (Mar 2019)Current year (2018)Next year (2019)
No. of analysts4244
Avg. EstimateN/AN/AN/A11.5M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A46M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid Date29/06/201829/09/2018
Est. EPSN/AN/A-0.31-0.34
Actual EPSN/AN/A-0.35-0.35
DifferenceN/AN/A-0.04-0.01
Surprise %N/AN/A-12.90%-2.90%
EPS trendCurrent qtr. (Dec 2018)Next qtr. (Mar 2019)Current year (2018)Next year (2019)
Current estimate-0.45-0.38-1.53-1
7 days ago-0.45-0.38-1.53-1
30 days ago-0.45-0.38-1.53-1
60 days ago-0.45-0.38-1.53-1.11
90 days ago-0.45-0.38-1.53-1.11
EPS revisionsCurrent qtr. (Dec 2018)Next qtr. (Mar 2019)Current year (2018)Next year (2019)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A1N/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesASLNIndustrySectorS&P 500
Current qtr.N/AN/AN/A0.05
Next qtr.N/AN/AN/A0.04
Current yearN/AN/AN/A0.10
Next year34.60%N/AN/A0.09
Next 5 years (per annum)N/AN/AN/A0.12
Past 5 years (per annum)N/AN/AN/AN/A